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artery disease. However, there is limited data on the subsequent hospitalizatons
and related direct health care costs among patients with pre-existing CKD under-
going percutaneous coronary intervention (PCI). We aimed to compare the rates
and costs of cardiac-related hospital readmissions following PCI in patients with
and without pre-existing CKD. METHODS: Direct health care costs were estimated
from 12,998 patients enrolled in the Melbourne Interventional Group (MIG) registry,
who underwent PCI between April 2004 and October 2010. Only individuals with
data on cardiovascular-related hospitalizations and medication use at 12-month
follow-up were included. Individual patient-procedures were assigned unit costs
based on published (DRG) data from the National Hospital Cost Data Collection for
Admissions in Victoria, Australia (2008-2009) and the Australian Pharmaceutical
Benefit Scheme schedule (2011-2012). A ‘bottom-up’ costing approach was used.
Costs relating to the index procedure and in-hospital complications were excluded.
Bootstrap linear regression was used to estimate the association between direct
medical costs and CKD categories, adjusting for age, gender and relevant
comorbidities. RESULTS: Excess cardiac-related readmissions occurred among pa-
tients with estimated glomerular filtration rate (eGFR)30 ml/min/1.73m2 (“severe
CKD or dialysis”, N330; 35%), compared to eGFR: 30-60 ml/min/1.73m2 (“moderate
CKD”, N2,648; 28%) or patients with eGFR60 ml/min/1.73m2(“referent group”,
N10,020; 24%). Adjusted mean (95%CI) total follow-up costs were significantly
higher in patients with severe CKD or dialysis [$AUD 2,206 ($AUD 1,148 - 3,688)].
CONCLUSIONS: Patients with severe CKD/dialysis undergoing PCI procedures in-
curred the highest mean direct health care costs at 12-month follow-up, compared
to those with better renal function. Hospitalization accounted for the majority of
these expenditures. Data gathered from this study have the potential to inform
policy makers of the likely economic impact of CKD in the context of invasive
treatment of CAD.
PSU11
MEDICAL COSTS COMPARISON BETWEEN INTERNAL FIXATION AND
ARTHOPLASTY IN PATIENTS WITH HIP FEMORAL NECK FRACTURES
Song X1, Shi N1, Yurgin N2, Varker H1, Dent R2, Bhandari M3
1Truven Health Analytics, Cambridge, MA, USA, 2Amgen Inc., Thousand Oaks, CA, USA,
3McMaster University, Hamilton, ON, Canada
OBJECTIVES: Surgery is common after a hip fracture. Two surgical options are
arthoplasty (AR) (i.e., hip replacement) or internal fixation (IF) (i.e., fixing the pa-
tient’s hip). Previous research suggests that AR is less costly than IF because IF
failure rate is high. This retrospective cohort study compared medical costs be-
tween IF and AR in patients with hip fractures of the femoral neck in a large US
population.METHODS: Patients50 years with IF or AR performed within 7 days of
a hip femoral neck fracture occurring between 7/1/2002 and 1/31/2010 were iden-
tified from the Marketscan database. Details on the specific location of the fracture
line within the femoral neck were not available. All patients had continuous insur-
ance coverage for 6 months prior to (pre-period) and 60 days following (post-period)
the surgery date (index date). Patients were followed from surgery date up to 18
months or until death, end of continuous enrollment, or end of study period (3/31/
2010), whichever came first. Generalized linear models on costs were used to adjust
different patient demographic and clinical characteristics. RESULTS: A total of
41,789 patients (mean age 80 years) were identified (60% IF and 40% AR patients).
Post-period mean monthly costs were similar between the two cohorts ($4344 for IF
vs. $4401 for AR, p0.339). Costs were the highest in the first month when the
surgery occurred and the IF cohort had lower cost than the AR cohort ($22,707 vs.
$25,646, p0.001). No statistically significant differences were found in the multi-
variate adjusted total mean monthly costs. The AR cohort had slightly higher in-
patient costs ($2642 for AR vs. $2469 for IF, p0.001) but lower outpatient costs
($1463 for AR vs. $1653 for IF, p0.001). CONCLUSIONS: In this large population,
both IF and AR interventions result in significant and similar health care costs.
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OBJECTIVES: Minimally Invasive Spinal Surgery (MIS) aim at minimizing muscle
trauma, reducing blood loss, decreasing postoperative pain, reducing surgery du-
ration and length of stay in hospital (LoS), and accelerate resuming normal activi-
ties for the patient. The objective of this study is to determine and compare the
resource consumption associated with OS vs. MIS in patients with degenerative
spinal disorder treated with a short construct. METHODS: This study was realized
in two French hospitals: one public and one private hospital, in which the learning
curve could be considered completed. To map the patient flow and estimate re-
source utilization, the clinical pathways of patients treated with open and MIS
spinal instrumentation were defined through interviews with medical staff. The
2009 French Hospitalization Costs Database (ENCC) updated with 2012 DRG tariffs,
was used to estimate the unit costs where differences were significant: 1) operating
room (OR), 2) LoS, 3) blood consumption. Costs were compared between both path-
ways (OS vs. MIS), in order to calculate the mean difference of costs. RESULTS: In
both hospitals MIS was associated with less resource use especially during surgery
and post-surgery episodes. This is mainly due to shorter OR time, LoS and less
blood loss. In the public case, 40% decrease in surgery time was observed, 38%
reduction in LoS and 100% decrease in blood consumption. In the private hospital,
28% decrease in surgery time, 41% reduction in LoS and 100% decrease in blood
consumption. The mean total costs saving associated with MIS corresponds to
1,469€ in the public hospital; and 652€ in the private hospital. CONCLUSIONS: MIS
potentially shortens operating and recovery time, decreases blood consumption,
and consequently reduces direct medical costs of hospital stays. This reduction
may offset the upfront investment (e.g. instrumentation). The findings are consis-
tent with published literature.
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OBJECTIVES: Osteoporotic vertebral compression fractures (OVCFs) are associated
with increased morbidity and mortality and with reduction in QoL. Vertebral aug-
mentation has been shown to be effective for treating these fractures. The associ-
ation between treatment and survivorship was analyzed in the Medicare Popula-
tion (Edidin 2010). Moreover, cost comparisons of kyphoplasty (BKP) and
vertebroplasty (VP) suggest that initial hospital costs are higher for BKP (Mehio
2011), while another study has reported cost effectiveness of BKP compared to VP
(Edidin 2012) Extensions of these analyses are necessary to verify the results for the
German setting. The purpose of the present study was to examine the overall
survival and treatment costs from a third payer perspective for OVCF patients
treated by VP or BKP. METHODS: To address the research questions claims, data of
a major health insurance fund (2.4 million insurants in 2011) were used. Groups
were established by propensity score matching adjusting for gender, age and over-
all comorbidity. For the matched OVCF-patients in the dataset (2006-2010) costs
were analyzed as well as survival was estimated by the Kaplan-Meier method.
RESULTS: A total of 598 newly diagnosed OVCF-patients who underwent vertebral
augmentation were identified from the data. After adjustment, 298 patients re-
mained. BKP-patients had a higher 60-month adjusted survival rate of 66.7%, com-
pared to 58.7% for VP-patients (p0.68). Cumulative 4-year mean overall costs
following the first diagnosis were lower for the BKP-cohort (VP: 42,510€ vs. BKP:
39,014€). Initially higher costs were mainly driven by costs for surgical treatment.
However, considerable pharmacy costs in VP-patients outweighed the primordially
lower inpatient costs. Major differences were found in costs for pain killers. (ATC
N02; VP: 3,321€ vs. BKP: 2,224€). CONCLUSIONS: Results suggest higher overall
survival for BKP-patients compared to VP-patients. Total costs were found to be
lower after 4 years for patients who received BKP due to lower pharmacy costs in
the long run.
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OBJECTIVES: Scoliosis is defined as a lateral deviation of the spine. Although most
of the curves are small to moderate and never necessitate intervention, some of
these curves progress and will require surgical interventions. These procedures are
associated with significant health care resources consumption. The objective of
this study was to assess the economic impact of scoliosis from a Canadian health
care system perspective. METHODS: Using a subset of 125,000 patients covered by
the provincial drug reimbursement program (Régie de l’assurance maladie du Qué-
bec (RAMQ)), a retrospective prescription and medical claims analysis was per-
formed. Patients who received a diagnosis of scoliosis (ICD9  737.3) from January
2003 to December 2011 were included in the analysis. Annual health care resources
utilization and costs were estimated for patients with scoliosis. Surgical proce-
dures associated with scoliosis were identified using the procedure codes found in
the RAMQ database. The costs and the resources utilization associated with the
surgical procedures were estimated over a one-year period from 30 days preceding
to 335 days following the surgery. RESULTS: Between January 2003 and December
2011, 523 individuals of the sample population received a diagnosis of scoliosis,
with a higher proportion of females (70.6%). Among these patients, 22 (4.2%) re-
quired at least one scoliosis surgery, for a total of 94 procedures. Most surgeries
were correction of the scoliosis via a posterior approach using Luke or Cotrel-
Dubousset segmental instrumentation (84% of all the procedures). The mean an-
nual medical cost associated with scoliosis was $4,865 while it was $29,777 for
patients who had a surgery. Annual medication cost were $1,178 for all patients
with scoliosis and $1,546 for patients who had a surgery. CONCLUSIONS: The eco-
nomic impact of scoliosis in Canada is substantial, especially when a surgical in-
tervention is required.
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OBJECTIVES: Anastomotic leaks after colorectal surgeries can lead to complica-
tions, and considerably increase medical resource use and cost. This study quan-
tified the incidence, and clinical and economic burden of anastomotic leaks follow-
ing colorectal surgeries in the US. METHODS: Premier Perspective database was
used to identify patients having a set of colorectal surgeries between Jan 2008 to
Dec 2010. The colorectal surgeries included colectomy, hemicolectomy, and rec-
tum resection. The anastomotic leak event was defined by re-operation, re-anas-
tomosis, stent, colostomy, drainage, and abscess within 30-day window following
the index colorectal surgeries. The index surgery and re-intervention were identi-
fied by ICD-9 procedure codes, CPT codes and Standard Charge Master codes. This
study entails two analyses: (1) the overall incidence rate of 30-day anastomotic
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